Relationship between glaucoma and selenium levels in plasma and aqueous humour

British Journal of Ophthalmology

Volumn 93, Issue 9, 2009, Pages 1155-1158

  Bruhn, R L ^a   Stamer, W D ^b   Herrygers, L A ^b   Levine, J M ^b   Noecker, R J ^b,c  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SELENIUM;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD SAMPLING; CONTROLLED STUDY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OPEN ANGLE GLAUCOMA; OUTCOME ASSESSMENT; PHACOEMULSIFICATION; PRIORITY JOURNAL; QUESTIONNAIRE; RISK FACTOR; TRABECULECTOMY; BLOOD; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; CHEMISTRY; COMPARATIVE STUDY; DRUG EFFECT; METABOLISM; MIDDLE AGED; RISK ASSESSMENT; TRABECULAR MESHWORK;

ADULT; AGED; AGED, 80 AND OVER; AQUEOUS HUMOR; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; GLAUCOMA, OPEN-ANGLE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES; RISK ASSESSMENT; SELENIUM; TRABECULAR MESHWORK;

EID: 70249117135     PISSN: 00071161     EISSN: 14682079     Source Type: Journal    
DOI: 10.1136/bjo.2007.125997     Document Type: Article

References (34)

1. The Eye Diseases Prevalence Research Group. Causes and prevalence of visual impairment among adults in the United States. Arch Ophthalmol 2004;122:477-485
2. Prevent Blindness America. Vision problems in the U.S. Baltimore: National Eye Institute, 2002.
3. Marshall JR, Reid ME, Lillico A, et al. Nutritional prevention of cancer: review of glaucoma data. Tucson: University of Arizona, 2002.
4. Lillico A, Jacobs E, Reid ME, et al. Selenium supplementation and risk of glaucoma in the NPC trial. Tucson: University of Arizona, 2002.
5. Jiang C, Jiang W, Ip C, et al. Selenium-induced inhibition of angiogenesis in mammary cancer at chemopreventive levels of intake. Mol Carcinog 1999;26:213-225
6. Hanahan D, Folkman J. Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 1996;86:353-364 (Pubitemid 26272076)
7. Bouck N, Stellmach V, Hsu SC. How tumors become angiogenic. Adv Cancer Res 1996;69:135-174
8. Jiang C, Ganther H, Lu J. Monomethyl selenium-specific inhibition of MMP-2 and VEGF expression: implications for angiogenic switch regulation. Mol Carcinog 2000;29:236-250 (Pubitemid 32052668)
9. Conley S, Bruhn R, Morgan P, et al. Selenium's effects on MMP-2 and TIMP-1 secretion by human trabecular meshwork cells. Invest Ophthalmol Vis Sci 2004;45:473-479 (Pubitemid 38140503)
10. Conley S, McKay B, Gandolfi AJ, et al. Alterations in human trabecular meshwork cell homeostatis by selenium. Exp Eye Res 2006;82:637-647 (Pubitemid 43122094)
11. Huang SH, Adamis AP, Wiedershain DG, et al. Matrix metalloproteinases and their inhibitors in aqueous humor. Expl Eye Res 1996;62:481-490
12. Yue BYJT. The extracellular matrix and its modulation in the trabecular meshwork. Survey Ophthalmol 1996;40:379-390 (Pubitemid 26117274)
13. McGahan MC, Grimes AM. Selenium concentration in ocular tissues and fluids. Ophthalmic Res 1991;23:45-50.
14. Taussky HH, Washington A, Zubillaga E, et al. Distribution of selenium in the tissues of the eye. Nature 1966;5039:949-950
15. Spallholz JE. On the nature of selenium toxicity and carcinostatic activity. Free Radic Biol Med 1994;17:45-64.
16. Oldfield JE. The two faces of selenium. J Nutr 1987;117:2002-2008
17. Cooper WC, Glover JR. The toxicology of selenium and its compounds. In: Zingaro R, Cooper WC, eds. Selenium. New York: Van Nostrand Reinhold Co., 1974.
18. Combs GFJ, Levander OA, Spallholz JE, Oldfield JE, eds. Selenium in biology and medicine. New York: An AVI book by Van Nostrand Reinhold, Co., 1987.
19. Neve J, Favier A, eds. Selenium in medicine and biology. Berlin, New York: Walter de Gruyter, 1989.
20. Muth OH, Oldfield JE, Weswig PH, eds. Selenium in biomedicine. Westport: AVI Publishing Co., Inc., 1967.
21. Levander OA. A global view of human selenium nutrition. Annu Rev Nutr 1987;7:227-250
22. Yang G, Yin S, Zhou R, et al. Studies of safe maximal daily dietary Se-intake in a seleniferous area in China. Part II: Relation between Se-intake and the manifestation of clinical signs and certain biochemical alterations in blood and urine. J Trace Elem Electrolytes Health Dis 1989;3:123-130 (Pubitemid 19260475)
23. Yang G, Wang S, Zhou R, et al. Endemic selenium intoxication of humans in China. Am J Clin Nutr 1983;37:872-881
24. Longnecker MP, Taylor PR, Levander OA, et al. Selenium in diet, blood, and toenails in relation to human health in a seleniferous area. Am J Clin Nutr 1991;53:1288-1294
25. Schrauzer GN, White DA. Selenium in human nutrition: dietary intakes and effects of supplementation. Bioinorg Chem 1978;8:303-318
26. Lu J, Jiang C, Kaeck M, et al. Dissociation of the genotoxic and growth inhibitory effects of selenium. Biochem Pharmacol 1995;50:213-219
27. Nyman DW, Suzanne Stratton M, Kopplin MJ, et al. Selenium and selenomethionine levels in prostate cancer patients. Cancer Detect Prev 2004;28:8-16. (Pubitemid 39403828)
28. Alward W, Johnson A, Nishimura D, et al. Molecular genetics of glaucoma: current status. J Glaucoma 1996;5:276-284 (Pubitemid 26267986)
29. Tielsch JM, Katz J, Sommer A, et al. Family history and risk of primary open angle glaucoma. The Baltimore Eye Survey. Arch Ophthalmol 1994;112:69-73.
30. Higginbotham EJ. Does sex matter in glaucoma? [Comment]. Arch Ophthalmol 2004;122:374-375
31. Sommer A. Glaucoma risk factors observed in the Baltimore Eye Survey. Curr Opin Ophthalmol 1996;7:93-98 (Pubitemid 26268836)
32. Girkin CA, Kannel WB, Friedman DS, et al. Glaucoma risk factor assessment and prevention: lessons from coronary heart disease. Am J Ophthalmol 2004;138:S11-S18. (Pubitemid 39198956)
33. Thomson CD. Selenium speciation in human body fluids. Analyst 1998;123:827-831
34. Brigelius-Flohe R. Tissue-specific functions of individual glutathione peroxidases. Free Rad Biol Med 1999;27:951-965 (Pubitemid 29507469)